Omalizumab for the Treatment of Multiple Food Allergies. Reply.

Wood, Robert A; Togias, Alkis; Chinthrajah, R Sharon

Wood, Robert A; Togias, Alkis; Chinthrajah, R Sharon.

Affiliation

Wood RA; Johns Hopkins University School of Medicine, Baltimore, MD rwood@jhmi.edu.
Togias A; National Institutes of Allergy and Infectious Diseases, Bethesda, MD.
Chinthrajah RS; Stanford University School of Medicine, Palo Alto, CA.

N Engl J Med ; 390(20): 1936, 2024 May 30.

Article in En | MEDLINE | ID: mdl-38810198

Subject(s)

Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Food Hypersensitivity; Omalizumab; Humans; Anti-Allergic Agents/therapeutic use; Antibodies, Anti-Idiotypic/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Food Hypersensitivity/drug therapy; Immunoglobulin E/blood; Immunoglobulin E/immunology; Omalizumab/therapeutic use; Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antibodies, Anti-Idiotypic / Anti-Allergic Agents / Antibodies, Monoclonal, Humanized / Omalizumab / Food Hypersensitivity Limits: Adult / Humans Language: En Journal: N Engl J Med Year: 2024 Type: Article Affiliation country: Moldova

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google